Status:
NOT_YET_RECRUITING
The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
Lead Sponsor:
NYU Langone Health
Conditions:
Post-Operative Pain
Total Knee Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that...
Eligibility Criteria
Inclusion
- Patients are candidates for elective primary total knee arthroplasty for a diagnosis of osteoarthritis or inflammatory arthritis.
- Patients have been medically cleared and scheduled for surgery
Exclusion
- Patients with cold-related conditions (cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, and Raynaud's disease)
- Surgery for fracture, infection, or malignancy
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT06991231
Start Date
June 1 2025
End Date
June 1 2026
Last Update
May 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016